Southern Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $278K | Hold |
2,199
| – | – | 0.14% | 67 |
|
|
2025
Q1 | $281K | Buy |
2,199
+2
| +0.1% | +$256 | 0.16% | 63 |
|
|
2024
Q4 | $290K | Buy |
2,197
+1
| +0% | +$132 | 0.16% | 55 |
|
|
2024
Q3 | $320K | Buy |
2,196
+3
| +0.1% | +$437 | 0.18% | 50 |
|
|
2024
Q2 | $301K | Hold |
2,193
| – | – | 0.19% | 50 |
|
|
2024
Q1 | $301K | Buy |
2,193
+2
| +0.1% | +$274 | 0.18% | 53 |
|
|
2023
Q4 | $298K | Sell |
2,191
-1,421
| -39% | -$193K | 0.21% | 47 |
|
|
2023
Q3 | $442K | Hold |
3,612
| – | – | 0.37% | 38 |
|
|
2023
Q2 | $459K | Sell |
3,612
-11,695
| -76% | -$1.48M | 0.35% | 39 |
|
|
2023
Q1 | $1.98M | Buy |
15,307
+2,346
| +18% | +$303K | 1.46% | 17 |
|
|
2022
Q4 | $1.7M | Buy |
12,961
+491
| +4% | +$64.5K | 1.32% | 19 |
|
|
2022
Q3 | $1.46M | Sell |
12,470
-2,491
| -17% | -$291K | 1.19% | 18 |
|
|
2022
Q2 | $1.76M | Buy |
14,961
+12,822
| +599% | +$1.51M | 1.4% | 18 |
|
|
2022
Q1 | $279K | Sell |
2,139
-22,533
| -91% | -$2.94M | 0.19% | 60 |
|
|
2021
Q4 | $3.77M | Buy |
+24,672
| New | +$3.77M | 2.33% | 11 |
|